Current Use of mTOR Inhibitors for the Treatment of Subependymal Giant Cell Astrocytomas and Epilepsy in Patients with TSC

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|23|37|4260-4269

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.37, 2016-12, pp. : 4260-4269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of mTOR inhibitors in the treatment of malignancies

By Mohindra Nisha A   Giles Francis J   Platanias Leonidas C  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 979-990

Informa Healthcare

Access to resources Recommend Favorite

mTOR inhibitors in the treatment of cancer

By Fasolo Angelica   Sessa Cristiana  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. : 1717-1734

Informa Healthcare

Access to resources Recommend Favorite

mTOR inhibitors as a new therapeutic option for epilepsy

By Curatolo Paolo   Moavero Romina  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 6, 2013-06 ,pp. : 627-638

Informa Healthcare

Access to resources Recommend Favorite

Anticancer Mammalian Target of Rapamycin (mTOR) Signaling Pathway Inhibitors: Current Status, Challenges and Future Prospects in Management of Epilepsy

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 8, 2016-09 ,pp. : 945-955

Bentham Science Publishers

Access to resources Recommend Favorite

The promise of mTOR inhibitors in the treatment of colorectal cancer

By Kim Dae-Dong   Eng Cathy  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 12, 2012-12 ,pp. : 1775-1788

Informa Healthcare

Access to resources Recommend Favorite